Filing Details
- Accession Number:
- 0000911916-17-000028
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-01-04 16:25:34
- Reporting Period:
- 2017-01-03
- Filing Date:
- 2017-01-04
- Accepted Time:
- 2017-01-04 16:25:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1348649 | Colucid Pharmaceuticals Inc. | CLCD | Pharmaceutical Preparations (2834) | 203419541 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1639976 | Bernice Kuca | C/O Colucid Pharmaceuticals, Inc. 222 Third Street Cambridge MA 02142 | Head,Clin. And Reg. Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-01-03 | 772 | $36.25 | 40,086 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Securities sold pursuant to a written plan intended to comply with Rule 10b5-1(c)(i) adopted by Ms. Kuca on August 15, 2016. One purpose of the plan is to sell shares of common stock acquired under the CoLucid Pharmaceuticals, Inc. Employee Stock Purchase Plan.
Billionaire Hedge Funds
